David Deaton
400 South Hope Street
Los Angeles, CA, 90071
Phone: +1-213-430-6191
Fax: +1-213-430-6407
George C. Demos
400 South Hope Street
Los Angeles, CA, 90071
Phone: +1-213-430-7862
Fax: +1-213-430-6407
Mark Easton
400 South Hope Street
Los Angeles, CA, 90071
Phone: +1-213-430-6549
Fax: +1-213-430-6407
Steven Grossman
1999 Avenue of the Stars, 7th Floor
Los Angeles, CA, 90067
Phone: +1-310-246-6727
Fax: +1-310-246-6779
Spencer Klein
Times Square Tower 7 Times Square
New York, NY, 10036
Phone: +1-212-326-2015
Fax: +1-212-326-2061
James Levin
400 South Hope Street
Los Angeles, CA, 90071
Phone: +1-213-430-6578
Fax: +1-213-430-6407
David Pommerening
1625 Eye Street, NW
Washington, DC, 20006
Phone: +1-202-383-5110
Fax: +1-202-383-5414
LAWYERS
Related Practices
American Capital Strategies, Ltd. CCMP Capital Advisors, LLC CIGNA Corporation Diagnostic Products Corporation (now Siemens AG) Emdeon Corporation Francisco Partners Goldman Sachs Capital Partners HCA Inc. JER Partners Quest Diagnostics Inc. Sirna Therapeutics, Inc. (now Merck & Co., Inc.) Specialty Laboratories
-
Sun Healthcare Group, Inc.
Vicuron Pharmaceuticals, Inc. (now Pfizer Inc.)
|

Health Care Mergers and Acquisitions
As merger and acquisition activity continues to grow in both volume and value, strategic and financial buyers are competing aggressively for investment opportunities on an unprecedented scale. In the health care industry, M&A transactions reached an all-time high in 2006, with US$260.7 billion committed to finance 991 health care–related deals. Deal volume and size continue to rise. In October 2007, a total of 102 deals in the healthcare sector–with over US$14.0 billion in commitments–demonstrate that M&A activity in the healthcare industry will be robust in 2008.
The Health Care M&A team at O’Melveny guides sophisticated companies and financial investors through the complexities of merging, acquiring, and disposing of health care businesses, whether public or private, domestic or international. In 2006, our clients entrusted us with more than 155 M&A transactions with an aggregate value of more than US$90 billion. In 2007, we kicked off the year with our high-profile representation of CCMP Capital Advisors and Goldman Sachs Capital Partners in their attempted US$6.4 billion acquisition of Triad Hospitals. Other M&A clients in the health-care sector include HCA Inc.; Merck & Co., Inc.; and CIGNA Corporation.
Key Facts
- Nightingale’s Healthcare News ranks O’Melveny 13th among the nation’s largest health care law practices.
- The 2006 Legal 500 recommended our London, Tokyo, and Hong Kong offices for M&A work, and spotlights the “high-profile deals” handled by our M&A lawyers in the United States.
- Thomson Financial ranked O’Melveny among the top 10 for European M&A deals with UK involvement (based on the first three quarters of 2006).
- Private Equity Analyst ranked our M&A practice fifth based on the number of private equity and venture capital deals we negotiated and closed in 2006.
- Corporate Control Alert ranked our M&A practice ninth for deals announced in 2006 valued at US$100 million or more.
Industry Reach
We represent a variety of clients in all sectors of the health care and life sciences industries:
- Biotechnology Companies
- Clinical Laboratories
- Dialysis Companies
- Health Care Internet Companies
- Health Care Services Companies
- Health Insurers and Managed Care Organizations
- Home Health Agencies
- Hospitals and Health Care Systems
- Investment Banks
- Private Equity, Venture Capital, and Other Investors
- Long-Term Care Companies and Assisted-Living Facilities
- Medical Device Manufacturers
- Medical Supply Manufacturers
- Pharmaceutical Manufacturers
Practice Strengths
-
Asset Purchases and Sales
-
Auctions
-
Contested Transactions
-
Financial Advisor Representations
-
Going Private Transactions
-
Joint Ventures
-
Leveraged Buyouts
-
Mergers
-
Proxy Contests
-
Recapitalizations
-
Spin-Offs and Split-Offs
-
Stock Purchases and Sales
-
Takeover Preparedness and Advice
-
Tender Offers
|
CCMP Capital Advisors, LLC and Goldman Sachs Capital Partners
Vicuron Pharmaceuticals, Inc
JER Partners
Emdeon Corporation
Sirna Therapeutics
Mindray Medical International Limited
|